BLASUBCUTANEOUSINJECTABLE
Approved
Dec 2024
Lifecycle
Growth
Competitive Pressure
30/100
Clinical Trials
1
Clinical Trials (1)
ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
Started Mar 2025
225 enrolled
Crohn DiseasePlaque Psoriasis